Skip to search formSkip to main contentSkip to account menu

CBR3 gene

Known as: Carbonyl Reductase 3 Gene, short chain dehydrogenase/reductase family 21C, member 2, SDR21C2 
This gene plays a role in the reduction of carbonyl-containing compounds.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PlncRNA‐1 has been suggested to function as an oncogenic role in prostate cancer, colorectal cancer, hepatocellular carcinoma… 
2018
2018
Objectives: To analyze the correlation between pharmacogenomic biomarkers and the efficacy of pirarubicin (THP, also named 4’-O… 
2010
2010
Doxorubicin (DOX) and daunorubicin (DAUN) are anthracycline anticancer agents; however, considerable interpatient variability… 
Review
2010
Review
2010
Enzymatic carbonyl reduction means the formation of a hydroxy function out of a ketone or aldehyde moiety and applies for the… 
2009
2009
PurposeRecent studies suggest that polymorphisms in human carbonyl reductase 3 (CBR3) influence the pharmacodynamics of… 
1984
1984
There is no shift of emission maximum (F470nm) of bovine serum albumin (BSA)-l-anilino-8-naphthatene sulphonic acid (ANS) complex…